Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06230367 · ClinicalTrials.gov registry record · NA
Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys
A NA study of HIV Infections, sponsored by Center for Innovative Public Health Research.
- Recruiting
- Registry status
- NA
- Development phase
- 5,000
- Enrollment target
- 2
- Study locations
NCT06230367: Recruiting NA study of HIV Infections, sponsored by Center for Innovative Public Health Research.
NCT06230367 is a NA study of HIV Infections that is actively recruiting participants, run by Center for Innovative Public Health Research. The registered enrollment target is 5,000 participants, above the 437-participant average among 542 other HIV Infections trials with a reported enrollment target (1044% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06230367, a NA study of HIV Infections, is actively recruiting participants, sponsored by Center for Innovative Public Health Research.
- RECRUITING
- Registry status
- NA
- Development phase
- 5,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
SHAG is a text messaging-based HIV prevention program designed for cisgender sexual minority boys and men 13-20 years of age across the United States. Investigators will test it against a control group that receives messages about healthy lifestyle.
Primary Outcome
HIV Incidence determined by home testing kit
Conditions Studied
Interventions
- BEHAVIORAL Sexual health advocacy for guys
- BEHAVIORAL Healthy lifestyle control
Study Locations (2)
California
- Center for Innovative Public Health Research - San Clemente
- Center for Innovative Public Health Research - San Clemente
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What NCT06230367 shows while recruiting
NCT06230367 is an interventional study that assigns participants to a tested intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 437-participant average among 542 other HIV Infections trials with a reported enrollment target (1044% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Sexual health advocacy for guys is the first listed.
NCT06230367 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06230367 about?
NCT06230367 is a clinical study titled "Sexual Health Advocacy for Guys - a Text Messaging-based HIV Prevention Program for Guys Who Are Into Guys". SHAG is a text messaging-based HIV prevention program designed for cisgender sexual minority boys and men 13-20 years of age across the United States. Investigators will test it against a control group that receives messages about healthy lifestyle.
What is the current status of trial NCT06230367?
This trial is currently recruiting. It is a NA study. The enrollment target is 5,000 participants. The study started on 2024-01-15. Estimated completion is 2026-07-31.
What conditions does trial NCT06230367 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT06230367?
The interventions under investigation include: Sexual health advocacy for guys (BEHAVIORAL), Healthy lifestyle control (BEHAVIORAL).
Who is sponsoring clinical trial NCT06230367?
This trial is sponsored by Center for Innovative Public Health Research, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06230367 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06230367's enrollment target sits among peer trials
5,000 5th of 542 higher than 537 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI